Lab On Chip Market Report 2026

Lab On Chip Market Overview

• Lab On Chip market size has reached to $8.85 billion in 2025 • Expected to grow to $16.25 billion in 2030 at a compound annual growth rate (CAGR) of 12.8% • Growth Driver: The Rising Adoption Of Personalized Medicine Is Fueling The Growth Of The Market Due To Its Ability To Enable Fast Accurate And Cost-Effective Genetic Analysis For Tailored Treatments • Market Trend: Advancements In Organs-On-Chip Technology For Accelerated Disease Modeling And Drug Testing • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Lab On Chip Market?

Lab on chip (LOC) is a compact device that combines multiple laboratory functions, including chemical analysis, biological assays, and diagnostics, onto a single chip. It precisely manipulates minute fluid volumes, delivering faster, cost-efficient, and high-throughput testing. They provide portable, efficient, and accurate laboratory analyses while minimizing reagent use and shortening turnaround times. The main types of lab on chip products and services are reagents and consumables, instruments, and software and services. Reagents and consumables are essential materials used to enable biological and chemical assays. It utilizes various technologies such as microfluidics-based technology, micro-electro-mechanical systems (MEMS), nanolithography, and three-dimensional (3D) printing technology with several materials, including polymers, glass, silicon, and paper. It is applicable in various applications such as genomics, proteomics, point-of-care diagnostics, drug discovery, and others, and is used by multiple end-users, including biotechnology and pharmaceutical companies, hospitals, diagnostic centers, academic and research institutes, and others.

What Is The Lab On Chip Market Growth Forecast?

The lab on chip market size is expected to see rapid growth in the next few years. It will grow to $16.25 billion in 2030 at a compound annual growth rate (CAGR) of 12.8%. The growth in the forecast period can be attributed to growth of decentralized healthcare testing, rising adoption in resource-limited settings, integration with digital health platforms, expansion of personalized diagnostics, increasing use in drug discovery. Major trends in the forecast period include miniaturization of diagnostic devices, growth of point of care testing, integration of multiple lab functions on chip, increased use of microfluidics, rising demand for rapid diagnostics.

Global Lab On Chip Market Segmentation

1) By Product And Service: Reagents And Consumables, Instruments, Software And Services 2) By Technology: Microfluidics-Based Technology, Micro-Electro-Mechanical Systems (MEMS), Nanolithography, Three-Dimensional (3D) Printing Technology 3) By Material: Polymers, Glass, Silicon, Paper 4) By Application: Genomics, Proteomics, Point Of Care Diagnostics, Drug Discovery, Other Applications 5) By End-User: Biotechnology And Pharmaceuticals Companies, Hospitals, Diagnostics Centers, Academic And Research Institutes, Other End-Users Subsegments: 1) By Reagents And Consumables: Enzymes And Buffers, Deoxyribonucleic Acid (DNA) Or Ribonucleic Acid (RNA) Extraction Kits, Microfluidic Cartridges, Microplates And Pipette Tips, Stains And Dyes 2) By Instruments: Microfluidic Analyzers, Lab-On-A-Chip Readers, Fluid Handling Systems, Imaging And Detection Systems, Automation And Robotics Platforms 3) By Software And Services: Data Analysis Software, Lab Management Software, Simulation And Modeling Software, Custom Development Services, Maintenance And Support Services

What Is The Driver Of The Lab On Chip Market?

The rising adoption of personalized medicine is expected to propel the growth of the lab on chip market going forward. Personalized medicine is a healthcare strategy that customizes prevention and treatment based on a person’s unique genetic makeup, environment, and lifestyle. Personalized medicine is growing due to genetic testing advancements that enable treatments to match an individual’s genetic makeup, enhancing effectiveness and minimizing side effects. Lab-on-chip devices allow fast and accurate analysis of a patient’s genetic and molecular information, enabling personalized treatments while lowering time and costs compared to conventional lab methods. For instance, in February 2024, according to the Personalized Medicine Coalition, a US-based non-profit organization, the Food and Drug Administration (FDA) approved 16 personalized therapies in 2023 aimed at treating rare diseases, marking a rise from the six such treatments approved in 2022. Therefore, the rising adoption of personalized medicine is driving the growth of the lab on chip industry.

Key Players In The Global Lab On Chip Market

Major companies operating in the lab on chip market are F. Hoffmann-La Roche Ltd., Merck KGaA, Thermo Fisher Scientific Inc., Danaher Corporation, Agilent Technologies Inc., Illumina Inc., Revvity Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Tecan Group Ltd, QuantuMDx Group Ltd., InSphero, Micronit B.V., MesoBioTech, Mimetas, Achira Labs Pvt. Ltd., Elvesys, Beonchip, Lab Chip Technologies, Sphere Bio.

Global Lab On Chip Market Trends and Insights

Major companies operating in the lab on chip market are focusing on developing advanced technological solutions, such as organ-on-chip technology-based instruments, to accelerate disease modeling and support personalized medicine applications. Organs-on-chip technology-based instruments are microfluidic devices that mimic human organ structure and function, allowing accurate simulation of biological processes and enabling precise drug testing and disease modeling outside the body. For instance, in September 2023, NETRI, a France-based provider of neuro-organs-on-chip technologies, launched organs-on-chip kits designed to enable faster and more predictive preclinical testing by integrating organs-on-chips into healthcare research processes. These kits support various species’ cells, allowing cross-species in vitro studies with predictive clinical insights, thereby accelerating drug candidate development and reducing reliance on animal models. This launch marks a significant step towards the widespread adoption of disruptive organs-on-chip technology in medical research.

What Are Latest Mergers And Acquisitions In The Lab On Chip Market?

In October 2024, Quris-AI, a US-based provider of AI-driven drug development and safety prediction platforms, acquired Nortis for an undisclosed amount. Through this acquisition, Quris-AI seeks to enhance its Bio-AI platform by integrating Nortis’s advanced organ-on-chip systems, strengthening its predictive capabilities for preclinical drug testing. Nortis is a US-based provider of microphysiology systems, including validated kidney-on-chip technologies designed for use in biomedical research and drug development.

Regional Outlook

North America was the largest region in the lab on chip market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Lab On Chip Market?

The lab on chip market consists of revenues earned by entities by providing services such as medical diagnostics, drug development and screening, point-of-care testing, and cell and tissue studies. The market value includes the value of related goods sold by the service provider or included within the service offering. The lab on chip market also includes sales of microfluidic analytical kits, genetic testing chips, organ-on-a-chip systems, and environmental monitoring chips. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.